Please Subscribe to get a daily link to Pat's blog via email

Subscribe!

Your privacy is important to us. We will never spam you and keep your personal data secure.

doxorubicin conjugate of milatuzumab

Home/Tag:doxorubicin conjugate of milatuzumab
27 11, 2010

Review About Using Anti-Bodies In Multiple Myeloma Therapy

Tags: , , , , |0 Comments

I have recieved a number of e-mail questions about the potential of using anti-bodies against multiple myeloma.  Here is an article I wrote in June following the large ASCO conference in Chicago which addressed this question:New Research Study Focuses On Antibodies To Stop Multiple MyelomaUpdate on another new anti-myeloma research study, post ASCO:Immunomedics doses first

8 11, 2010

Hope For Multiple Myeloma Patients When Revlimid & Velcade Stop Working

Tags: , , , , , , , , , |2 Comments

I have received a number of calls and e-mails recently from patients who's multiple myeloma has become active again while using Revlimid, Velcade, or both.  Here is a short, hopeful response I found addressing this on the Multiple Myeloma Research Foundation (MMRF) Website:Treatment Options for Relapsed or Refractory Patients Failing Revlimid and Velcade: Q&A with

20 06, 2010

New Research Study Focuses On Antibodies To Stop Multiple Myeloma

Tags: , |0 Comments

Update on another new anti-myeloma research study, post ASCO:Immunomedics doses first patient in Phase I/II multiple myeloma trialImmunomedics, a biopharmaceutical company, has announced the dosing of the first patient in a Phase I/II clinical trial of the doxorubicin conjugate of milatuzumab for the treatment of patients with relapsed multiple myeloma. The open-label, multi-center Phase I/II